Cephalosporin Drugs Market to reach a market size of $14.1 billion by 2025
The Global Cephalosporin Drugs Market size is expected to reach $14.1 billion by 2025, rising at a market growth of 3.34% CAGR during the forecast period.
(firmenpresse) - According to a new report Global Cephalosporin Drugs Market, published by KBV Research, The Global Cephalosporin Drugs Market size is expected to reach $14.1 billion by 2025, rising at a market growth of 3.34% CAGR during the forecast period.
The Third-Generation Cephalosporin Drugs market dominated the Global Cephalosporin Drugs Market by Generation in 2018, growing at a CAGR of 3.6 % during the forecast period. The Second-Generation Cephalosporin Drugs market is expected to witness a CAGR of 3.2% during (2019-2025).
The Injections market dominated the Global Cephalosporin Drugs Market by Route of Administration in 2018, growing at a CAGR of 3.3 % during the forecast period. The Oral Drugs market is expected to witness a CAGR of 3.5% during (2019-2025).
The Asia Pacific market dominated the Global Skin Infection Market by Region in 2018, growing at a CAGR of 3.1 % during the forecast period. The Europe market is expected to witness a CAGR of 3.3% during (2019-2025). Additionally, The North America market is expected to witness a CAGR of 5.1% during (2019-2025).
Full Report: https://www.kbvresearch.com/cephalosporin-drugs-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of ABBOTT Laboratories, Teva Pharmaceuticals Industries Ltd., Johnson and Johnson, GlaxoSmithKline PLC (GSK), Pfizer, Inc., Merck & Co., Inc., Bayer AG, Baxter International, Inc., Bristol-Myers Squibb Company and Novartis AG.
Global Cephalosporin Drugs Market Segmentation
By Generation
First-Generation Cephalosporin
Second-Generation Cephalosporin
Third-Generation Cephalosporin
Fourth-Generation Cephalosporin
Fifth-Generation Cephalosporin
By Application
Respiratory Tract Infection
Skin Infection
Ear Infection
Sexually Transmitted Infection
Others
By Route of Administration
Injections
Oral Drugs
By Type
Branded
Generic
By Geography
North America
US
Canada
Mexico
Rest of North America
Europe
Germany
UK
France
Russia
Spain
Italy
Rest of Europe
Asia Pacific
China
Japan
India
South Korea
Singapore
Malaysia
Rest of Asia Pacific
LAMEA
Brazil
Argentina
UAE
Saudi Arabia
South Africa
Nigeria
Rest of LAMEA
Companies Profiled
ABBOTT Laboratories
Teva Pharmaceuticals Industries Ltd.
Johnson and Johnson
GlaxoSmithKline PLC (GSK)
Pfizer, Inc.
Merck & Co., Inc.
Bayer AG
Baxter International, Inc.
BRISTOL-MYERS SQUIBB COMPANY
Novartis AG
Cephalosporin Drugs Market Related Reports:
North America Market
Europe Market
Asia Pacific Market
LAMEA Market
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
KBV Research is Knowledge Based Value Research, which is a global brand and consulting firm serving all kinds of business verticals, government and non-governmental organizations, and not-for-profit organizations. Our motto is to extend our services that will have a lasting impact on our clients who trust us with their business goals. KBV Research is a global market research and consulting company offering syndicated and custom market research reports with exhaustive industry analysis.
244 Fifth Avenue, Suite 1407
New York, N.Y. 10001
United States (U.S)
Tel: +1 (646) 661-6066
Email: info(at)kbvresearch.com
Datum: 23.09.2019 - 01:58 Uhr
Sprache: Deutsch
News-ID 1552422
Anzahl Zeichen: 3583
contact information:
Contact person: Prity Singh
Town:
New York
Phone: 6466616066
Kategorie:
Healthcare & Medical
Typ of Press Release: Product
type of sending: send
Date of sending: 23.09.2019
Anmerkungen:
Diese Pressemitteilung wurde bisher 423 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Cephalosporin Drugs Market to reach a market size of $14.1 billion by 2025
"
steht unter der journalistisch-redaktionellen Verantwortung von
KBV Research (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
